Charles Oo

1.1k total citations
28 papers, 737 citations indexed

About

Charles Oo is a scholar working on Pharmacology, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Charles Oo has authored 28 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 10 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Charles Oo's work include Influenza Virus Research Studies (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Drug Transport and Resistance Mechanisms (5 papers). Charles Oo is often cited by papers focused on Influenza Virus Research Studies (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Drug Transport and Resistance Mechanisms (5 papers). Charles Oo collaborates with scholars based in United States, United Kingdom and Switzerland. Charles Oo's co-authors include Penelope Ward, George Hill, Albert Dorr, Nirmala S. Desai, Joanne Barrett, Regina Dutkowski, Patrick J. McNamara, Baolian Liu, Robert J. Kuhn and Hugh Wiltshire and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Frontiers in Microbiology.

In The Last Decade

Charles Oo

28 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Oo United States 15 383 179 138 130 128 28 737
K Neftel Switzerland 17 204 0.5× 122 0.7× 63 0.5× 241 1.9× 222 1.7× 42 1.2k
Geoffrey Warhurst United Kingdom 22 297 0.8× 413 2.3× 95 0.7× 171 1.3× 112 0.9× 34 1.4k
D. Henzel France 22 225 0.6× 191 1.1× 51 0.4× 231 1.8× 87 0.7× 59 1.1k
Peggy Gandia France 16 293 0.8× 91 0.5× 101 0.7× 143 1.1× 76 0.6× 75 1.0k
Patricia Lizak United States 15 118 0.3× 69 0.4× 107 0.8× 296 2.3× 143 1.1× 23 637
Charles la Porte Canada 13 199 0.5× 131 0.7× 99 0.7× 478 3.7× 48 0.4× 30 970
Jomy George United States 17 313 0.8× 106 0.6× 122 0.9× 357 2.7× 30 0.2× 34 1.1k
Britt Jansson Sweden 14 192 0.5× 118 0.7× 89 0.6× 80 0.6× 46 0.4× 18 804
Rosa María López Spain 18 326 0.9× 103 0.6× 144 1.0× 534 4.1× 40 0.3× 44 888
Sara Baldelli Italy 23 178 0.5× 115 0.6× 331 2.4× 583 4.5× 94 0.7× 67 1.3k

Countries citing papers authored by Charles Oo

Since Specialization
Citations

This map shows the geographic impact of Charles Oo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Oo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Oo more than expected).

Fields of papers citing papers by Charles Oo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Oo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Oo. The network helps show where Charles Oo may publish in the future.

Co-authorship network of co-authors of Charles Oo

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Oo. A scholar is included among the top collaborators of Charles Oo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Oo. Charles Oo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yue, Jiali, Peijuan Zhu, Charles Oo, et al.. (2023). Physiologically-based pharmacokinetic modeling to inform dosing regimens and routes of administration of rifampicin and colistin combination against Acinetobacter baumannii. European Journal of Pharmaceutical Sciences. 185. 106443–106443. 6 indexed citations
2.
Lv, Zhihua, et al.. (2022). Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic Modeling. Clinical Pharmacokinetics. 61(10). 1427–1441. 13 indexed citations
3.
Zhang, Jiayuan, Yuwei Liu, Charles Oo, et al.. (2022). Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant Acinetobacter baumannii. Frontiers in Microbiology. 13. 1013934–1013934. 8 indexed citations
4.
Zhang, Jiayuan, Yanfei Liu, Hongxiang Wang, et al.. (2022). The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant Acinetobacter baumannii. Frontiers in Microbiology. 13. 1024702–1024702. 8 indexed citations
5.
Oo, Charles & Sherwin K. B. Sy. (2019). Learning and augmenting natural processes: potential means of combating antimicrobial resistance from a drug R&D perspective. Drug Discovery Today. 25(1). 1–3. 11 indexed citations
6.
Itoh, Soichi & Charles Oo. (2009). A feasibility study of differential delivery of levodopa ester and benserazide using site-specific intestinal loops in rats. Journal of Pharmaceutical Sciences. 99(1). 227–233. 2 indexed citations
7.
Itoh, Seiji, et al.. (2006). Reciprocating dialysis tube method: Periodic tapping improved in vitro release/dissolution testing of suppositories. European Journal of Pharmaceutics and Biopharmaceutics. 64(3). 393–398. 15 indexed citations
8.
Kurowski, Michael, Charles Oo, Hugh Wiltshire, & Joanne Barrett. (2004). Oseltamivir Distributes to Influenza Virus Replication Sites in the Middle Ear and Sinuses. Clinical Drug Investigation. 24(1). 49–53. 15 indexed citations
9.
Dutkowski, Regina, et al.. (2003). Safety and Pharmacology of Oseltamivir in Clinical Use. Drug Safety. 26(11). 787–801. 91 indexed citations
10.
Oo, Charles, et al.. (2003). Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsules. International Journal of Pharmaceutics. 257(1-2). 297–299. 22 indexed citations
11.
Oo, Charles, George Hill, Albert Dorr, et al.. (2003). Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1?5�years. European Journal of Clinical Pharmacology. 59(5-6). 411–415. 52 indexed citations
12.
Hill, George, Tomáš Cihlář, Charles Oo, et al.. (2002). The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion—Correlation of in Vivo and in Vitro Studies. Drug Metabolism and Disposition. 30(1). 13–19. 99 indexed citations
13.
Oo, Charles, Joanne Barrett, Albert Dorr, Baolian Liu, & Penelope Ward. (2002). Lack of Pharmacokinetic Interaction between the Oral Anti-Influenza Prodrug Oseltamivir and Aspirin. Antimicrobial Agents and Chemotherapy. 46(6). 1993–1995. 20 indexed citations
14.
Oo, Charles, et al.. (2002). Lack of pharmacokinetic interaction between the oral anti‐influenza neuraminidase inhibitor prodrug oseltamivir and antacids. British Journal of Clinical Pharmacology. 54(4). 372–377. 19 indexed citations
15.
Oo, Charles, Joanne Barrett, George Hill, et al.. (2001). Pharmacokinetics and Dosage Recommendations for an Oseltamivir Oral Suspension for the Treatment of Influenza in Children. Pediatric Drugs. 3(3). 229–236. 67 indexed citations
16.
Oo, Charles, et al.. (2001). Active Transport of Nitrofurantoin into Rat Milk. Advances in experimental medicine and biology. 501. 547–552. 9 indexed citations
17.
Gerk, Phillip M., et al.. (2001). Interactions between Cimetidine, Nitrofurantoin, and Probenecid Active Transport into Rat Milk. Journal of Pharmacology and Experimental Therapeutics. 296(1). 175–180. 35 indexed citations
18.
Bonate, Peter L., et al.. (2000). Clonazepam and Sertraline: Absence of Drug Interaction in a Multiple-Dose Study. Journal of Clinical Psychopharmacology. 20(1). 19–27. 11 indexed citations
19.
Oo, Charles, et al.. (1995). Pharmacokinetics of Caffeine and Its Demethylated Metabolites in Lactation: Predictions of Milk to Serum Concentration Ratios. Pharmaceutical Research. 12(2). 313–316. 20 indexed citations
20.
Oo, Charles, Robert J. Kuhn, Nirmala S. Desai, & Patrick J. McNamara. (1995). Active transport of cimetidine into human milk*. Clinical Pharmacology & Therapeutics. 58(5). 548–555. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K Neftel Breakdown of academic impact, for papers by Geoffrey Warhurst Breakdown of academic impact, for papers by D. Henzel Breakdown of academic impact, for papers by Peggy Gandia Breakdown of academic impact, for papers by Patricia Lizak Breakdown of academic impact, for papers by Charles la Porte Breakdown of academic impact, for papers by Jomy George Breakdown of academic impact, for papers by Britt Jansson Breakdown of academic impact, for papers by Rosa María López Breakdown of academic impact, for papers by Sara Baldelli
Rankless by CCL
2026